Navigation Links
Pharma's Premier EPI Database Launches New Forecast Period and Disease Indications
Date:5/7/2009

Rich Data Set and Easy-to-Use Web Interface Allows Users to Manipulate Data to Create Custom Epidemiological Projections

PatientBase Also Offers Treatable Pools for Its Cancer Indications

WALTHAM, Mass., May 7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announces the completion of PatientBase's forecast period and disease indication updates. The forecast period now reflects 2008 to 2018 data. PatientBase is the premier epidemiology database for the pharmaceutical industry, providing complete coverage of more than 140 disease indications including over 711 patient populations across the G7 pharmaceutical markets (U.S., France, Germany, Italy, Spain, United Kingdom and Japan).

"In response to our clients' needs we are continuously working on updating PatientBase," stated Amanda Wilson, epidemiologist and product manager at Decision Resources. "Its rich data set and easy-to-use Web interface allows our clients to focus on the age cohort, country, disease subtype (including comorbidity), disease subpopulation segment of interest or specific years to meet their unique needs and research objectives."

PatientBase also offers treatable pools for its cancer indications. Treatable pools can be used for greater accuracy in forecasting and sizing a cancer market by taking into account both relevant patient populations and patient populations by stages.

For a complete list of updated indications, please contact Natalia Morales at nmorales@dresources.com or Elizabeth Marshall at emarshall@dresources.com.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Natalia Morales           Elizabeth Marshall
    Decision Resources        Decision Resources, Inc.
    781-296-2691              781-296-2563
    nmorales@dresources.com   emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pharmasset to Present at Two Upcoming Investor Conferences
2. Pharmasset to Present at Two Upcoming Investor Conferences
3. ePharmaSolutions Adds Several Industry Clinicians to its Rater Certification and Data Monitoring Department
4. Pharmasset to Present at the 27th Annual JPMorgan Healthcare Conference
5. Parkland Health & Hospital System Rolls Out Innovations PharmASSIST Technology Platform Across Nine Pharmacy Sites
6. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
7. Pharmasset to Webcast an Investor Event from the AASLD Meeting
8. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
9. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
10. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
11. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s best ... Dermatitis Associated with Borrelia Infection” reveals that a condition similar to ... prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is an ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... California (PRWEB) , ... December 07, 2016 , ... "ProBrand ... any and all media," said Christina Austin - CEO of Pixel Film Studios. , ... with easy to use drop zones. Editors can select from a variety of flip ...
(Date:12/7/2016)... ... 07, 2016 , ... “The Road To Restoration”: an informative and enlightening ... hour a week showing of hands. “The Road To Restoration” is the creation of ... familiar with the brass ring that you could reach out for, and grab, on ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... Angioma ... by cerebral cavernous angiomas, was awarded a grant from the Julian Grace Foundation ... New Mexico has more people with cavernous angioma than anywhere in the world. ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016   AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... , Business Process Manager, for being named to ... Baldrige National Quality Award by the Commerce Department,s ... the organization,s commitment to process excellence. The Baldrige ...
(Date:12/6/2016)... 2016  BTL Aesthetics today announced the release ... Vanquish ME device was effectively redesigned for more ... targeted tissue. The result: Significantly better outcomes in ... Vanquish ME versus BTL Vanquish. "We ... their patients with the most highly-advanced devices on ...
(Date:12/6/2016)... Dec. 6, 2016 With opioids commonly used for pain ... prescription drug market that has led to nationwide fatalities. ... eight times stronger than heroin or morphine, resulting in likelihood of ... , ... vice president, clinical operations, Behavioral Health for HMC HealthWorks, explained the ...
Breaking Medicine Technology: